Co-Authors
This is a "connection" page, showing publications co-authored by Gili Regev-Yochay and Yaniv Lustig.
Connection Strength
1.533
-
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021 10 14; 385(16):1474-1484.
Score: 0.240
-
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel. Lancet Reg Health Eur. 2021 Aug; 7:100150.
Score: 0.239
-
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021 09; 9(9):999-1009.
Score: 0.239
-
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel. Euro Surveill. 2021 07; 26(26).
Score: 0.238
-
The Sheba Medical Center healthcare workers' children's school: can we open schools safely? Clin Microbiol Infect. 2021 Mar; 27(3):474.e1-474.e3.
Score: 0.229
-
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis. PLoS One. 2020; 15(11):e0241164.
Score: 0.229
-
Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine. Am J Obstet Gynecol. 2021 11; 225(5):577-579.
Score: 0.060
-
SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses. Epidemiol Infect. 2021 06 24; 149:e153.
Score: 0.060